Table 1. In vivo role of Ag presentation in ovx-induced T cell expansion.
T cells in S phase, % of T cells | T cells in sub-G0/G1 phase, % of T cells | TNF-producing T cells, % of BM white cells | |
---|---|---|---|
DO 11.10 sham | 2.23 ± 0.4 | 0.56 ± 0.2 | 0.43 ± 0.1 |
DO 11.10 ovx | 1.87 ± 0.7 | 0.78 ± 0.4 | 0.32 ± 0.1 |
DO 11.10 sham + ovalbumin | 4.4 ± 0.5* | 1.6 ± 0.2* | 0.67 ± 0.2 |
DO 11.10 ovx + ovalbumin | 14.1 ± 2.6*† | 0.7 ± 0.1† | 1.8 ± 0.4*† |
Ovx fails to increase T cell proliferation (cells in S phase), to decrease T cell apoptosis (cells in sub-G10/G1 phase), and to increase BM T cells in DO 11.10 mice (mean ± SEM).
P < 0.05 as compared to untreated shams.
P < 0.05 as compared to ovalbumin-treated shams.